期刊
PHYSIOLOGICAL REVIEWS
卷 92, 期 1, 页码 101-130出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physrev.00021.2011
关键词
-
类别
资金
- National Institutes of Health [HL-59699, DK-38226]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059699] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER
Imig JD. Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology. Physiol Rev 92: 101-130, 2012; doi: 10.1152/physrev.00021.2011.-Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that importantly contribute to vascular and cardiac physiology. The contribution of EETs to vascular and cardiac function is further influenced by soluble epoxide hydrolase (sEH) that degrades EETs to diols. Vascular actions of EETs include dilation and angiogenesis. EETs also decrease inflammation and platelet aggregation and in general act to maintain vascular homeostasis. Myocyte contraction and increased coronary blood flow are the two primary EET actions in the heart. EET cell signaling mechanisms are tissue and organ specific and provide significant evidence for the existence of EET receptors. Additionally, pharmacological and genetic manipulations of EETs and sEH have demonstrated a contribution for this metabolic pathway to cardiovascular diseases. Given the impact of EETs to cardiovascular physiology, there is emerging evidence that development of EET-based therapeutics will be beneficial for cardiovascular diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据